Close Menu
Global News HQ
    What's Hot

    Epic Universe Has a Restaurant Honoring Pan-Asian Cuisine With Food, Decor, and Hidden Motifs

    July 4, 2025

    Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool

    July 4, 2025

    Want to Avoid Microplastics in Food? We Found the 8 Most Common Foods That Contain Microplastics

    July 4, 2025
    Recent Posts
    • Epic Universe Has a Restaurant Honoring Pan-Asian Cuisine With Food, Decor, and Hidden Motifs
    • Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool
    • Want to Avoid Microplastics in Food? We Found the 8 Most Common Foods That Contain Microplastics
    • Solana Whale Moves $152 Million In One Splash—What’s Going On?
    • NYC’s top deals: $13M condo trades at Witkoff and Access’ One High Line
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Epic Universe Has a Restaurant Honoring Pan-Asian Cuisine With Food, Decor, and Hidden Motifs
    • Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool
    • Want to Avoid Microplastics in Food? We Found the 8 Most Common Foods That Contain Microplastics
    • Solana Whale Moves $152 Million In One Splash—What’s Going On?
    • NYC’s top deals: $13M condo trades at Witkoff and Access’ One High Line
    • The World Is Getting Warmer. Fashion Thinks it Can Handle the Heat.
    • Tally lets you design great free surveys in 60 seconds
    • Who Makes Lucid Cars?
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Finance & Investment - Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool
    Finance & Investment

    Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool
    Share
    Facebook Twitter LinkedIn Pinterest Email

    One day before the July Fourth holiday, the stock of clinical-stage biotech Summit Therapeutics (SMMT 8.18%) exploded like a powerful fireworks display. Shares of the cancer-focused company leaped by 8%, on a media report that a well-known peer was interested in a licensing deal. That rise bettered the S&P 500‘s (^GSPC 0.83%) 0.8% increase by several orders of magnitude.

    15 billion new reasons to consider the stock

    The media outlet in question was Bloomberg, which that morning published an article asserting that AstraZeneca is in talks with Summit about a partnership between the two companies.

    Image source: Getty Images.

    According to unnamed “people familiar with the matter,” the piece stated that such a partnership would center on the investigational lung cancer treatment ivonescimab. The drug, which Summit licenses from Chinese peer Akeso, has recently attracted much attention from the healthcare community and investors alike. This was due to its impressive performance in a late-stage clinical trial.

    Bloomberg’s sources said that the terms of a potential deal were still being hashed out. They might include an up-front payment of several billion dollars, and several milestone payments over time (this kind of structure is common in pharmaceutical industry licensing/partnership arrangements). All told, a deal between the two companies could pay out as much as $15 billion.

    Both Summit and AstraZeneca declined comment on the Bloomberg article.

    Fingers crossed

    When a drug development program attracts $15 billion worth of interest from a major industry player with deep pockets, it’s almost indisputably a win. If the Bloomberg report is accurate and a deal is indeed in the works (and is ultimately agreed upon), it would open a great, powerful, and quick road to success for Summit. It’s little wonder investors were so happy about the possibility.

    Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleSome Drugs Can Make You Extra Vulnerable to Sun and Heat
    Next Article Hurry, Lowe’s Is Giving Away Free Ego Batteries for the 4th of July

    Related Posts

    Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool

    July 4, 2025

    UBS and Citi among nine banks fined $21.5mn in Singapore money-laundering case

    July 4, 2025

    Stars, Stripes, And A $4 Trillion Tab

    July 4, 2025

    The Best FSA or HSA-Eligible Prime Day Deals You Can Shop Now

    July 4, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Travel & Tourism (Luxury)
    5 Mins Read

    Epic Universe Has a Restaurant Honoring Pan-Asian Cuisine With Food, Decor, and Hidden Motifs

    There’s one lone dragon making a huge roar at Universal Orlando Resort’s new theme park…

    Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool

    July 4, 2025

    Want to Avoid Microplastics in Food? We Found the 8 Most Common Foods That Contain Microplastics

    July 4, 2025

    Solana Whale Moves $152 Million In One Splash—What’s Going On?

    July 4, 2025
    Top
    Travel & Tourism (Luxury)
    5 Mins Read

    Epic Universe Has a Restaurant Honoring Pan-Asian Cuisine With Food, Decor, and Hidden Motifs

    There’s one lone dragon making a huge roar at Universal Orlando Resort’s new theme park…

    Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool

    July 4, 2025

    Want to Avoid Microplastics in Food? We Found the 8 Most Common Foods That Contain Microplastics

    July 4, 2025
    Our Picks
    Travel & Tourism (Luxury)
    5 Mins Read

    Epic Universe Has a Restaurant Honoring Pan-Asian Cuisine With Food, Decor, and Hidden Motifs

    There’s one lone dragon making a huge roar at Universal Orlando Resort’s new theme park…

    Finance & Investment
    2 Mins Read

    Should Stock Market Investors Buy Home Depot Stock Right Now in July 2025? | The Motley Fool

    Home Depot (NYSE: HD) management is focusing on serving the professional customer as home improvement…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version